Miura, Y., Mouri, A., Kaira, K., Yamaguchi, O., Shiono, A., Hashimoto, K., . . . Kagamu, H. Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events. Wiley.
Chicago Style (17th ed.) CitationMiura, Yu, et al. Chemoradiotherapy Followed by Durvalumab in Patients with Unresectable Advanced Non‐small Cell Lung Cancer: Management of Adverse Events. Wiley.
MLA (9th ed.) CitationMiura, Yu, et al. Chemoradiotherapy Followed by Durvalumab in Patients with Unresectable Advanced Non‐small Cell Lung Cancer: Management of Adverse Events. Wiley.
Warning: These citations may not always be 100% accurate.